You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康基醫療(09997.HK)中期經調整利潤1.37億元 同比增長5.1%
格隆匯 08-25 22:54

格隆匯 8 月 25日丨康基醫療(09997.HK)公佈,截至2020年6月30日止6個月,實現收入2.13億元(人民幣,下同),同比下降1.6%;毛利1.78億元,同比下降1.3%;非《香港財務報告準則》經調整期內利潤1.37億元,同比增長5.1%;母公司擁有人應占利潤8074.2萬元,同比下降3.4%;基本每股盈利11.92分。

收入減少主要是由於COVID-19疫情對公司2020年第一季度銷售額的影響,部分被2020年第二季度的銷售額恢復所抵銷。

純利為8960萬元,較2019年同期減少31.4%,主要歸因於分別約3210萬元及1560萬元的上市開支及以股份為基礎的付款開支。母公司擁有人應占利潤減少3.4%是由於:(i)集團純利減少,及(ii)為籌備在聯交所上市而於2020年3月進行重組,最終抵銷非控股權益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account